Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Proto Labs (PRLB) EBT Margin (2016 - 2025)

Historic EBT Margin for Proto Labs (PRLB) over the last 14 years, with Q3 2025 value amounting to 7.57%.

  • Proto Labs' EBT Margin fell 2800.0% to 7.57% in Q3 2025 from the same period last year, while for Sep 2025 it was 4.37%, marking a year-over-year decrease of 25600.0%. This contributed to the annual value of 4.93% for FY2024, which is 6200.0% down from last year.
  • Latest data reveals that Proto Labs reported EBT Margin of 7.57% as of Q3 2025, which was down 2800.0% from 4.94% recorded in Q2 2025.
  • Proto Labs' 5-year EBT Margin high stood at 13.2% for Q2 2021, and its period low was 100.95% during Q4 2022.
  • Moreover, its 5-year median value for EBT Margin was 5.63% (2021), whereas its average is 0.3%.
  • Its EBT Margin has fluctuated over the past 5 years, first tumbled by -1114100bps in 2022, then surged by 1089000bps in 2023.
  • Proto Labs' EBT Margin (Quarter) stood at 10.46% in 2021, then plummeted by -1065bps to 100.95% in 2022, then soared by 108bps to 7.95% in 2023, then tumbled by -103bps to 0.23% in 2024, then skyrocketed by 3369bps to 7.57% in 2025.
  • Its last three reported values are 7.57% in Q3 2025, 4.94% for Q2 2025, and 4.74% during Q1 2025.